Page last updated: 2024-09-03

gefitinib and abt-737

gefitinib has been researched along with abt-737 in 1 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(abt-737)
Trials
(abt-737)
Recent Studies (post-2010) (abt-737)
5,2315662,9196320484

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)abt-737 (IC50)
Bcl-2-like protein 11Homo sapiens (human)0.002
Apoptosis regulator Bcl-2Homo sapiens (human)0.0206
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)0.0003
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)0.0003
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)0.0003
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)0.0003
Adenosine receptor A2aRattus norvegicus (Norway rat)0.02
BH3-interacting domain death agonistHomo sapiens (human)0.0485
Apoptosis regulator BAX Homo sapiens (human)0.023
Bcl-2-like protein 1Homo sapiens (human)0.0207
Induced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)0.0248
Aspartyl/asparaginyl beta-hydroxylaseHomo sapiens (human)3.44
Bcl-2 homologous antagonist/killerHomo sapiens (human)0.0335
Bcl-2-like protein 2Homo sapiens (human)0.0335
Bcl-2-binding component 3, isoforms 1/2Homo sapiens (human)0.0003

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cragg, MS; Huang, DC; Kuroda, J; Puthalakath, H; Strasser, A1

Other Studies

1 other study(ies) available for gefitinib and abt-737

ArticleYear
Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics.
    PLoS medicine, 2007, Volume: 4, Issue:10

    Topics: Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Biphenyl Compounds; Carcinoma, Non-Small-Cell Lung; Cell Death; Cell Line, Tumor; Drug Synergism; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Membrane Proteins; Mutation; Nitrophenols; Piperazines; Proto-Oncogene Proteins; Quinazolines; Sulfonamides

2007